PATHEON MANUFACTURING SERVICES, LLC

Featured products of Patheon

Iclusig

Iclusig FC tab 15 mg

ponatinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EA05 - ponatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.

Kadcyla

Kadcyla powd for infusion 100 mg

trastuzumab emtansine

Packing/Price

15 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XC14 - trastuzumab emtansine : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.

Kadcyla powd for infusion 160 mg

trastuzumab emtansine

Packing/Price

20 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XC14 - trastuzumab emtansine : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.

Distributed by Roche

Kadcyla

Kadcyla powd for infusion 100 mg

trastuzumab emtansine

Packing/Price

15 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XC14 - trastuzumab emtansine : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.

Kadcyla powd for infusion 160 mg

trastuzumab emtansine

Packing/Price

20 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XC14 - trastuzumab emtansine : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.

Distributed by Zuellig

Iclusig

Iclusig FC tab 15 mg

ponatinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EA05 - ponatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.

Marketed by Otsuka (Philippines)

Iclusig

Iclusig FC tab 15 mg

ponatinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EA05 - ponatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.